Sign in
Active, not recruitingNo phase

Continuous And Data-drivEN CarE (CADENCE) Pilot

Key facts

Who runs it
University of South Florida
Where
Tampa, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
10 people, planned
Started
23 Aug 2023
Expected to end
30 Sept 2027
Type of study
Interventional
Treatments tested
  • CADENCE program
Record updated
10 November 2025

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Patients with known opioid use disorder over the age of 18 years old who are pregnant

Who cannot take part

  • Patients without opioid use disorder, less than 18 years old, incarcerated, or non-pregnant

Where in United States

  • University of South Florida (Tampa General Hospital)Tampa, United States

About the trial

What the trial wants to find out

The proposed project seeks to use public health and clinical data on opioid use disorders (OUD) outcomes for mother and infants, which is the leading cause of death to mothers one year after deliver and can lead to neonatal withdrawal syndrome (NOWS) and other poor outcomes. Insufficient or incomplete data about OUD and lack of integrated programs for OUD treatment during pregnancy can be barriers to providing optimal care to mothers and infants.

The group in the trial

  • CADENCE program pilotTreatment being tested

    Treatment: CADENCE program

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Continuous And Data-drivEN CarE (CADENCE)
Publications
Record updated
10 November 2025